Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Retirement Fund median (29 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Apr 2024 – 20 Aug 2026, limited by PGIM India Retirement Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | PGIM India Retirement Fund | Nifty 500 |
|---|---|---|
| 19 Apr 2024 | ₹100.00 | ₹100.00 |
| 29 Jun 2024 | ₹111.30 | ₹110.67 |
| 08 Sep 2024 | ₹117.01 | ₹115.17 |
| 18 Nov 2024 | ₹111.80 | ₹107.43 |
| 28 Jan 2025 | ₹107.00 | ₹102.65 |
| 09 Apr 2025 | ₹105.20 | ₹99.86 |
| 20 Jun 2025 | ₹119.61 | ₹113.03 |
| 30 Aug 2025 | ₹119.01 | ₹110.19 |
| 09 Nov 2025 | ₹120.01 | ₹115.39 |
| 19 Jan 2026 | ₹115.61 | ₹114.66 |
| 31 Mar 2026 | ₹103.80 | ₹100.70 |
| 10 Jun 2026 | ₹115.21 | ₹109.07 |
| 20 Aug 2026 | ₹125.82 | ₹115.34 |
| Metric | PGIM India · Regular NAV ₹12.57 High risk ★☆☆☆☆ 1Y | Category median Retirement Fund · 29 funds |
|---|---|---|
| +2.44% | +3.06% | |
| — | +9.73% | |
| — | +8.56% | |
| — | +9.67% | |
| +10.33% | +9.51% | |
| +7.54% | — | |
| — | +11.33% | |
| — | +10.95% | |
| — | +10.29% | |
| Risk | ||
| 14.28% | 10.68% | |
| -0.28 | 0.26 | |
| -0.39 | 0.35 | |
| -17.14% | -18.07% | |
| Nifty 500 | — | |
| — | +0.14% | |
| — | 0.76 | |
| — | 79.3% | |
| — | 73.1% | |
| 2.60% | 2.16% | |
| ₹97.87Cr | ₹280.84Cr | |
| None | — | |
| 5 years | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 15% | 24% | |
| Padmanabhan Anjeneyan · 8.7y | — | |
| 19 Apr 2024 | — | |
| 87 | — | |
| 27.0% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.